Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 10, 2015-10 ,pp. : 1354-1362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does tocilizumab contribute to elevation of rheumatoid factor and induction of paradoxical syaloadenitis in rheumatoid arthritis patients?

By Martinović Kaliterna Dušanka   Aljinović Jure   Perković Dijana   Marasović Krstulović Daniela   Marinović Ivanka   Vlak Tonko  

Wiener klinische Wochenschrift, Vol. 126, Iss. 3-4, 2014-02 ,pp. : 126-129

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of switching to entecavir monotherapy in Japanese lamivudine‐pretreated patients

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 5, 2010-05 ,pp. : 892-898

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subcutaneous abatacept for the treatment of rheumatoid arthritis

By Schiff Michael  

British Journal of Rheumatology , Vol. 52, Iss. 6, 2013-06 ,pp. : 986-997

Oxford University Press

Access to resources Recommend Favorite

Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

By Hochberg Marc C.   Berry Scott   Broglio Kristine   Rosenblatt Lisa   Nadkarni Anagha   Trivedi Digisha   Hebden Tony  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1213-1222

Informa Healthcare

Access to resources Recommend Favorite